Form 4: Cardio Diagnostics Holdings Director James Intrater Reports Stock Option Transaction
SEC Form 4 Filing
Director James Intrater reports acquisition and disposal of stock options in Cardio Diagnostics Holdings.
Summary
- On September 30, 2024, James Intrater, a director of Cardio Diagnostics Holdings, Inc., reported a transaction involving stock options.
- Intrater acquired 18,686 stock options with an exercise price of $0.22 on September 30, 2024, exercisable immediately and expiring on September 30, 2034.
- Intrater disposed of 26,261 stock options.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.
Stakeholder Impact
- The transaction may be of interest to shareholders as it provides insight into the director's holdings and sentiment.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of earliest transaction: Acquisition of 18,686 stock options and disposal of 26,261 stock options. |
| 09/30/2024 | Date stock options exercisable. |
| 09/30/2034 | Expiration date of stock options. |
| 10/10/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.